Warning letter
Alpha Therapeutic Corporation: warning letter of Mar 30, 2000
FDA warning letter UCM068285 · Los Angeles District Office
Key facts
| Reference number | UCM068285 |
|---|---|
| Company | Alpha Therapeutic Corporation |
| Subject | Blood & Blood Components |
| Issue date | Mar 30, 2000 |
| Posted date | Mar 30, 2000 |
| Issuing office | Los Angeles District Office |
| Product type | Biologics |
| CFR sections cited | 606.60(a), 606.60(b) |
| Country | 3 |
| Inspection city | Fontana |
| Inspection ZIP | 92335-3860 |
| Inspection start date | Feb 23, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: